A detailed history of Schrum Private Wealth Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Schrum Private Wealth Management LLC holds 31,302 shares of PFE stock, worth $833,259. This represents 0.47% of its overall portfolio holdings.

Number of Shares
31,302
Previous 20,644 51.63%
Holding current value
$833,259
Previous $577,000 56.85%
% of portfolio
0.47%
Previous 0.52%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$27.7 - $31.39 $295,226 - $334,554
10,658 Added 51.63%
31,302 $905,000
Q2 2024

Jul 30, 2024

SELL
$25.26 - $29.6 $111,371 - $130,506
-4,409 Reduced 17.6%
20,644 $577,000
Q1 2024

May 02, 2024

BUY
$25.89 - $29.73 $214,783 - $246,640
8,296 Added 49.51%
25,053 $695,000
Q4 2023

Jan 25, 2024

SELL
$26.13 - $33.94 $266,081 - $345,611
-10,183 Reduced 37.8%
16,757 $482,000
Q3 2023

Nov 06, 2023

BUY
$32.09 - $37.51 $3,914 - $4,576
122 Added 0.45%
26,940 $893,000
Q2 2023

Jul 24, 2023

BUY
$36.12 - $41.79 $686 - $794
19 Added 0.07%
26,818 $983,000
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $7,208 - $9,384
-183 Reduced 0.68%
26,799 $1.09 Million
Q4 2022

Jan 19, 2023

SELL
$41.75 - $54.5 $43,545 - $56,843
-1,043 Reduced 3.72%
26,982 $0
Q3 2022

Oct 26, 2022

SELL
$43.76 - $53.42 $22,186 - $27,083
-507 Reduced 1.78%
28,025 $1.23 Million
Q2 2022

Jul 22, 2022

SELL
$46.53 - $55.17 $2,326 - $2,758
-50 Reduced 0.17%
28,532 $1.5 Million
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $549 - $680
12 Added 0.04%
28,582 $1.44 Million
Q4 2021

Mar 11, 2022

BUY
$41.32 - $61.25 $1.18 Million - $1.75 Million
28,570 New
28,570 $1.69 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Schrum Private Wealth Management LLC Portfolio

Follow Schrum Private Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schrum Private Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schrum Private Wealth Management LLC with notifications on news.